A Study to Evaluate Glucose and Insulin Response to Nutralin
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01275820|
Recruitment Status : Completed
First Posted : January 12, 2011
Last Update Posted : January 12, 2011
|Condition or disease||Intervention/treatment|
|Diabetes||Dietary Supplement: Nutralin|
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||A Study to Evaluate Glucose and Insulin Response to Nutralin|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||August 2010|
|Actual Study Completion Date :||September 2010|
All 10 subjects in the study will consume the investigational food product.
Dietary Supplement: Nutralin
Food product to be taken 15 minutes prior to each of the three main meals of the day.
Other Name: No other names at this time.
- Glucose blood level [ Time Frame: 4 weeks ]Measure the change in blood sugar levels
- Dosage of Insulin [ Time Frame: 4 weeks ]Measure the levels of insulin
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01275820
|United States, South Dakota|
|Avera Research Institute|
|Sioux Falls, South Dakota, United States, 57105|
|Principal Investigator:||Edward Zawada, MD||Avera McKennan Hospital & University Health Center|